(688566)"Jiangsu Jibeier Pharmaceutical Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 688566 · · 13 pages · Chinese
Summary by 6ix AI
The report confirms the accuracy and completeness of the financial information provided, with the board and management assuming legal responsibility for its content. Key financial data includes revenue and profit figures, indicating significant changes compared to the previous period. The report also outlines the company's total assets and shareholders' equity as of the reporting date.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Jiangsu Jibeier Pharmaceutical Co. Ltd. on 6ix
Earlier from Jiangsu Jibeier Pharmaceutical
- (688566)"Jiangsu Jibeier Pharmaceutical Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Voluntary Disclosure of Obtaining an Invention Patent
- Announcement on Appointment of the Board Secretary
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Notice on Convening the 1st Extraordinary General Meeting in 2026
Later from Jiangsu Jibeier Pharmaceutical
All Jiangsu Jibeier Pharmaceutical news releasesFollow Jiangsu Jibeier Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Jibeier Pharmaceutical